Logotype for Solitron Devices Inc

Solitron Devices (SODI) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Solitron Devices Inc

Q2 2026 earnings summary

10 Oct, 2025

Executive summary

  • Net sales for the quarter ended August 31, 2025, increased 11% year-over-year to $3.99 million, driven by improved backlog and order delivery timing.

  • Net bookings surged 147% to $4.32 million, and backlog rose 146% to $18.64 million compared to the prior year.

  • Revenue increased sequentially from $2.70 million in the first quarter to $3.99 million in the second quarter.

  • Operating loss for the quarter was $291,000, primarily due to increased stock-based compensation and higher administrative expenses.

  • Net loss for the quarter was $234,000, or ($0.11) per share, compared to net income of $17,000 in the prior year period.

Financial highlights

  • Gross profit for the quarter was $835,000, up from $738,000 year-over-year, with gross margin steady at 21%.

  • For the six months, net sales decreased 11% to $6.69 million, and gross profit fell to $1.23 million (18% margin) from $2.41 million (32% margin) year-over-year.

  • Net loss for the six months was $570,000, compared to net income of $606,000 in the prior year.

  • Operating cash flow for the six months was $777,000, down from $1.55 million in the prior year.

  • Cash and cash equivalents at quarter-end were $2.85 million, down from $4.10 million at the prior fiscal year-end.

Outlook and guidance

  • Management expects cash from operations and current cash balances to be sufficient to fund capital expenditures and operations for the next twelve months.

  • Anticipated capital expenditures for the next year are approximately $250,000.

  • The company may pursue acquisitions, new product lines, or investments in securities to utilize net operating loss carryforwards.

  • Sales are expected to reach a steadier level in the third and fourth quarters of fiscal 2026.

  • Anticipation of receiving the AMRAAM Lot 39 order in the third quarter, with expected order quantities about 10% higher and pricing increased due to the expiration of a multi-year agreement.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more